Shares of Danaher Corporation (NYSE:DHR – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-two brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $238.65.
Several brokerages recently weighed in on DHR. Robert W. Baird reduced their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. UBS Group lowered their price target on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Evercore lifted their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Wolfe Research reduced their price target on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th.
View Our Latest Analysis on DHR
Insider Transactions at Danaher
Institutional Investors Weigh In On Danaher
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Main Street Group LTD bought a new stake in Danaher during the 1st quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter worth $26,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the third quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Down 1.6%
DHR stock opened at $161.95 on Wednesday. Danaher has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a market cap of $114.62 billion, a PE ratio of 31.32, a price-to-earnings-growth ratio of 2.20 and a beta of 0.81. The business has a 50 day moving average of $186.30 and a 200 day moving average of $210.38.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the company earned $1.88 EPS. On average, research analysts forecast that Danaher will post 8.43 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 1.0%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
